Webinaire
Protection from birth: Expanding access to hepatitis B birth dose
The World Health Organization (WHO) estimates that 254 million people were living with chronic hepatitis B infection (HBV) in 2022 and 1.3 million new infections each year. Hepatitis B Birth Dose (HepB-BD) vaccine, given within 24 hours after birth and followed by at least two subsequent doses, is approximately 90% effective at preventing perinatal HBV infection. By the end of 2023, only 17 countries in AFRO had introduced HepB BD; in EMRO, all but 5 countries have introduced the vaccine.
Since the launch of the Gavi HepB-BD vaccine programme in June 2024, 12 countries have been approved, with introductions planned for 2025 and 2026.
WHO in collaboration with Gavi and other partners conducted an interactive webinar to provide information to stakeholders in countries that plan to apply for Gavi support.
This webinar:
- Shared WHO recommendations, guidance and tools for introducing HepB BD vaccine
- Shared the global and regional Triple objectives Elimination goals and targets
- Provided an update on the available Gavi support for countries to introduce HepB BD vaccine, including implications for countries moving into Gavi 6.0.
- Answered any questions or address concerns of countries/ Gavi teams and alliance partners on the new programme.
The video is also available on TechNet with interpretation in French.
Auteurs
- Funmi Lesi
- Sidy Ndiaye
-
Simbarashe Mabaya
Voir le profil | Plus d’articles - Louise Henaff
- Muhammad Shahid Jamil
-
Stephanie Shendale
Voir le profil | Plus d’articles
Langues
Date
2025-10-01
Type
Webinaire
Catégories
- Gestion de programme
Maladies
- Hépatite B
Organisations
- Gavi, l'Alliance du vaccin
- Organisation Mondiale de la Santé (OMS)
Mots-clés
- SAGE
TN-WEBINAR-2025
| Titre | Auteur | Année | Type | Langue |
|---|---|---|---|---|
| Using digital technologies to enhance implementation of home- based records/ personal health records for maternal, newborn and child health | Laura Nic Lochlainn, Natschja Ratanaprayul, Hassan Sibomana, Pawan Kumar, Tomoya Yoshida, Annie Portela | 2025 | Webinar | Anglais, Français |
| Launch of "Operational Guidance: Multisectoral zero-dose strategies to improve routine immunization and other child outcomes" and accompanying case study compendium | Ibrahim Dadari, Desiree Stewart | 2025 | Webinar | Anglais, Arabe, Français, Espagnol |
| Alternative methods for the validation of maternal and neonatal tetanus elimination (MNTE) in armed conflict and other access-constrained settings | Nasir Yusuf | 2025 | Webinar | Anglais, Français |
| Show me the data! Deep dive into understanding and optimizing vaccine wastage rates and resupply decisions | Laila Akhlaghi, Wendy Prosser | 2025 | Webinar | Anglais |
| Ask Me Anything about EVM and cIP | Dan Brigden, Olamide Folorunso, Zainab Berry, Erida Nelaj | 2025 | Webinar | Anglais |
| Dissemination for the targeted and selective strategies in measles and rubella vaccination campaigns: interim guidance | Oniovo Efe-Aluta, Santosh Gurung | 2025 | Webinar | Anglais, Français |
| Rabies elimination – the basics | Bernadette Abela, Frederic Lohr, Zsofia Hesketh, Juan Pablo Arguello Yepez, Kerenza Vlastou, Lunsungu Ngulube, Simbarashe Mabaya | 2025 | Webinar | Anglais, Français |
| Protection from birth: Expanding access to hepatitis B birth dose | Funmi Lesi, Sidy Ndiaye, Simbarashe Mabaya, Louise Henaff, Muhammad Shahid Jamil, Stephanie Shendale | 2025 | Webinar | Anglais, Français |
| Catch-Up Vaccination: Insights from 5 Big Catch-up Country Case Studies | Daniela Rodriguez, Ariel Higgins-Steele, Victoria Ngako, Chisom Obi-Jeff, Chinyere Okeke, Makki Ahmed, Stephen Mshana, Sheikh Al-Shoteri, Stephanie Shendale | 2025 | Webinar | Anglais, Arabe, Français |
| Introduction to Post Market Monitoring of cold chain equipment | Paul Mallins, Edda Magnus, Matt Morio, Danya Arif Siddiqi | 2025 | Webinar | Anglais |
| Reaching Zero-Dose Children: Insights from Six Implementation Research Studies | Daniela Rodriguez, Collins Buh, Dora Dadzie, Sylvestre Bemanana, Dziko Chatata, Lucia Vieira, Rutaba Syed, Jane Dzoole, Sylvester Maleghemi | 2025 | Webinar | Anglais, Français |
| WHO PCV vaccination recommendations: 1p+1 dose schedules | Alejandro Ramirez Gonzalez, Johanna Fihman, Maya M.V.X. van den Ent, Nathalie Salagnac | 2025 | Webinar | Anglais, Français |